Naik, V. R., Munikumar, M., Ramakrishna, U., Srujana, M., Goudar, G., Naresh, P., . . . Hemalatha, R. (2020). Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach. J Biomol Struct Dyn.

Naik, Vankudavath Raju, Manne Munikumar, Ungarala Ramakrishna, Medithi Srujana, Giridhar Goudar, Pittla Naresh, Boiroju Naveen Kumar, und Rajkumar Hemalatha. "Remdesivir (GS-5734) As a Therapeutic Option of 2019-nCOV Main Protease – in Silico Approach." J Biomol Struct Dyn 2020.

Naik, Vankudavath Raju, et al. "Remdesivir (GS-5734) As a Therapeutic Option of 2019-nCOV Main Protease – in Silico Approach." J Biomol Struct Dyn 2020.